Functional Kinase Activity Biomarkers in clinical translational research
- Prosjektnummer
- 2011030
- Ansvarlig person
- Vessela N. Kristensen
- Institusjon
- Akershus universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
Genome Biol 2016 Dec 09;17(1):250. Epub 2016 des 9
PMID: 27931250
Determinants of acquired activated protein C resistance and D-dimer in breast cancer.
Thromb Res 2016 Sep;145():78-83. Epub 2016 aug 3
PMID: 27505249
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.
EMBO Mol Med 2016 Sep 01;8(9):1052-64. Epub 2016 sep 1
PMID: 27485121
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients.
Cancer Res 2016 Sep 15;76(18):5326-36. Epub 2016 jul 12
PMID: 27406829
Subtype-specific micro-RNA expression signatures in breast cancer progression.
Int J Cancer 2016 Sep 01;139(5):1117-28. Epub 2016 mai 9
PMID: 27082076
Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer.
Genome Med 2015;7(1):21. Epub 2015 feb 2
PMID: 25873999
Glycan-related gene expression signatures in breast cancer subtypes; relation to survival.
Mol Oncol 2015 Apr;9(4):861-76. Epub 2015 jan 14
PMID: 25655580
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Carcinogenesis 2014 Jan;35(1):76-85. Epub 2013 okt 8
PMID: 24104550 - Inngår i doktorgradsavhandlingen
Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.
BMC Cancer 2014;14():211. Epub 2014 mar 19
PMID: 24645668
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma.
PLoS One 2013;8(8):e72692. Epub 2013 aug 30
PMID: 24023633 - Inngår i doktorgradsavhandlingen
Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.
ISRN Oncol 2012;2012():176789. Epub 2012 mai 14
PMID: 22666610
Tyrosine Kinase Activity Profiling Reveals Differences According to Progesterone-Receptor-Status in HER2 Negative Breast Cancer
San Antonio Breast Cancer Symposium 2015
Age and estrogen-dependent inflammation in breast adenocarcinoma and normal breast tissue
submitted to Molecular Oncology
Differential kinase inhibition in BRAF(V600E) positive metastatic malignant melanoma by vemurafenib
under 2 revision, inngår i avhandlingen
Tyrosine kinase profiling in metastatic malignant melanoma: Identification of possible therapeutic targets and prediction marker
Annual meeting American Association for Cancer Research, Chicago 2012
REGULATORY AND FUNCTIONAL GENOMIC BIOMARKERS IN BREAST CANCER AND MELANOMA
- Disputert:
- mars 2016
- Hovedveileder:
- Vessela N. Kristensen
- Ida Rashida Khan Bukholm Prosjektdeltaker
- Torben Luders Prosjektdeltaker
- Vessela N. Kristensen Hovedveileder
- Jürgen Geisler Medveileder
- Andliena Tahiri Doktorgradsstipendiat (finansiert av denne bevilgning)
- Rik de Wijn Prosjektdeltaker
- Venkata Satheesh Somisetty Prosjektdeltaker
- David Quigley Prosjektdeltaker
- Antoni Hurtado Rodriguez Prosjektdeltaker
- Miriam Ragle Aure Postdoktorstipendiat
- Anne Hansen Ree Prosjektdeltaker
- Kathrine Røe Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport